Your browser doesn't support javascript.
loading
Prognostic potency of plasma LRG1 measurement at multiple time points in acute ischemic stroke patients.
Gu, Juxian; Liu, Chao; Yao, Yan.
Affiliation
  • Gu J; Department of Neurology, Cangzhou Central Hospital, Cangzhou, 061001, China.
  • Liu C; Department of CT Diagnosis, Cangzhou Central Hospital, Cangzhou, 061001, China.
  • Yao Y; Department of Neurology, Cangzhou Central Hospital, Cangzhou, 061001, China.
Biomark Med ; 18(5): 181-190, 2024 Mar.
Article in En | MEDLINE | ID: mdl-38440887
ABSTRACT

Objective:

This study aimed to investigate the prognostic potency of LRG1 in acute ischemic stroke (AIS) patients.

Methods:

Plasma LRG1 levels were detected at admission and on days 3, 7 and 30 in 150 AIS patients.

Results:

LRG1 positively correlated with total cholesterol (p = 0.016), triglycerides (p = 0.046), C-reactive protein (p < 0.001), TNF-α (p = 0.001) and IL-6 (p = 0.004). After admission, LRG1 showed a decreasing trend (p < 0.001). Interestingly, LRG1 levels at admission (p = 0.014), day 3 (p = 0.027), day 7 (p = 0.008) and day 30 (p = 0.002) were higher in patients with modified Rankin scale score ≥2 versus those with scores <2. The LRG1 levels at day 7 (p = 0.032) and day 30 (p = 0.023) were higher in patients with recurrence versus no recurrence.

Conclusion:

LRG1 correlates with blood lipids, inflammation and short-term prognosis of AIS.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stroke / Ischemic Stroke Limits: Humans Language: En Journal: Biomark Med Journal subject: BIOQUIMICA / MEDICINA Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stroke / Ischemic Stroke Limits: Humans Language: En Journal: Biomark Med Journal subject: BIOQUIMICA / MEDICINA Year: 2024 Document type: Article Affiliation country: